Barclays Maintains an 'Overweight' on Laboratory Corporation (LH); Orchid Cellmark (ORCH) Deal Wins FTC Approval
Go back to Barclays Maintains an 'Overweight' on Laboratory Corporation (LH); Orchid Cellmark (ORCH) Deal Wins FTC Approval| Laboratory Corp. of America Holding (NYSE: LH) | Delayed: 318.13 -4.46 (1.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $322.59 | 52 Week High | $141.32 | |||
| Open | $317.35 | 52 Week Low | $97.79 | |||
| Day High | $322.99 | P/E | 50.90 | |||
| Day Low | $317.06 | EPS | $6.25 | |||
| Volume | 436,291 | |||||
| Orchid Cellmark, Inc. (NASDAQ: ORCH) | Delayed: 2.79 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.79 | 52 Week High | $2.81 | |||
| Open | $25.50 | 52 Week Low | $1.85 | |||
| Day High | $2.79 | P/E | N/A | |||
| Day Low | $2.79 | EPS | $-0.15 | |||
| Volume | 106,088 | |||||
